Literature DB >> 18511277

Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90.

Thomas E Barta1, James M Veal, John W Rice, Jeffrey M Partridge, R Patrick Fadden, Wei Ma, Matthew Jenks, Lifeng Geng, Gunnar J Hanson, Kenneth H Huang, Amy F Barabasz, Briana E Foley, James Otto, Steven E Hall.   

Abstract

Hsp90 maintains the conformational stability of multiple proteins implicated in oncogenesis and has emerged as a target for chemotherapy. We report here the discovery of a novel small molecule scaffold that inhibits Hsp90. X-ray data show that the scaffold binds competitively at the ATP site on Hsp90. Cellular proliferation and client assays demonstrate that members of the series are able to inhibit Hsp90 at nanomolar concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511277     DOI: 10.1016/j.bmcl.2008.05.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  16 in total

1.  Inhibition of heat-shock protein 90 reduces Ebola virus replication.

Authors:  Darci R Smith; Sarah McCarthy; Andrew Chrovian; Gene Olinger; Andrea Stossel; Thomas W Geisbert; Lisa E Hensley; John H Connor
Journal:  Antiviral Res       Date:  2010-05-07       Impact factor: 5.970

2.  POVME 3.0: Software for Mapping Binding Pocket Flexibility.

Authors:  Jeffrey R Wagner; Jesper Sørensen; Nathan Hensley; Celia Wong; Clare Zhu; Taylor Perison; Rommie E Amaro
Journal:  J Chem Theory Comput       Date:  2017-08-30       Impact factor: 6.006

Review 3.  Design, synthesis, and evaluation of small molecule Hsp90 probes.

Authors:  Tony Taldone; Danuta Zatorska; Pallav D Patel; Hongliang Zong; Anna Rodina; James H Ahn; Kamalika Moulick; Monica L Guzman; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2011-03-12       Impact factor: 3.641

4.  Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity.

Authors:  Preeti Putcha; Karin M Danzer; Lisa R Kranich; Anisa Scott; Melanie Silinski; Sarah Mabbett; Carol D Hicks; James M Veal; Paul M Steed; Bradley T Hyman; Pamela J McLean
Journal:  J Pharmacol Exp Ther       Date:  2009-11-24       Impact factor: 4.030

5.  Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.

Authors:  Tony Taldone; Pallav D Patel; Maulik Patel; Hardik J Patel; Christopher E Evans; Anna Rodina; Stefan Ochiana; Smit K Shah; Mohammad Uddin; Daniel Gewirth; Gabriela Chiosis
Journal:  J Med Chem       Date:  2013-08-21       Impact factor: 7.446

6.  Inhibition of HSP90 with pochoximes: SAR and structure-based insights.

Authors:  Sofia Barluenga; Jean-Gonzague Fontaine; Cuihua Wang; Kais Aouadi; Ruihong Chen; Kristin Beebe; Len Neckers; Nicolas Winssinger
Journal:  Chembiochem       Date:  2009-11-23       Impact factor: 3.164

7.  Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis.

Authors:  Magdi E A Zaki; Sami A Al-Hussain; Syed Nasir Abbas Bukhari; Vijay H Masand; Mithilesh M Rathore; Sumer D Thakur; Vaishali M Patil
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-01

8.  Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods.

Authors:  Jianling Liu; Fangfang Wang; Zhi Ma; Xia Wang; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2011-01-30       Impact factor: 5.923

9.  Synthesis and Activity of a New Series of Antileishmanial Agents.

Authors:  Ankush Kanwar; Benjamin J Eduful; Linda Barbeto; Piero Carletti Bonomo; Andrea Lemus; Brian A Vesely; Tina S Mutka; Ala Azhari; Dennis E Kyle; James W Leahy
Journal:  ACS Med Chem Lett       Date:  2017-07-31       Impact factor: 4.632

10.  Re-refinement from deposited X-ray data can deliver improved models for most PDB entries.

Authors:  Robbie P Joosten; Thomas Womack; Gert Vriend; Gérard Bricogne
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.